Emerging prognostic and predictive factors in pancreatic cancer.

Karamitopoulou, Eva (2023). Emerging prognostic and predictive factors in pancreatic cancer. Modern pathology, 36(11), p. 100328. Elsevier 10.1016/j.modpat.2023.100328

[img] Text
1-s2.0-S0893395223002338-main.pdf - Accepted Version
Restricted to registered users only until 13 September 2024.
Available under License Publisher holds Copyright.

Download (3MB) | Request a copy

Pancreatic cancer is a lethal disease with increasing incidence and high recurrence rates, currently resistant to conventional therapies. Moreover, it displays extensive morphological and molecular intra- and intertumoral heterogeneity and a mostly low mutational burden, failing to induce significant antitumor immunity. Thus, immunotherapy has shown limited effect in pancreatic cancer, except in rare tumors with microsatellite instability, constituting <1% of the cases. Currently, new methods, including single cell and single nucleus RNA sequencing, have refined and expanded the two-group molecular classification based on bulk RNA sequencing (classical and basal-like subtypes), identifying hybrid forms and providing us with a comprehensive map of the tumor cell subsets that drive gene expression during tumor evolution, simultaneously giving us insight to therapy resistance and metastasis. Additionally, deeper profiling of the tumor microenvironment of pancreatic cancer by using spatial analyses and multiplex imaging techniques, have improved our understanding of the heterogeneous distribution of both adaptive and innate immune components with their protumor and antitumor properties. By integrating host immune response patterns, as defined by spatial transcriptomic and proteomic analysis and multiplex immunofluorescence, with molecular and morphologic features of the tumors we can increasingly understand the genetic, immunologic and morphologic background of pancreatic cancer and recognize the potential predictors for different treatment modalities.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Karamitopoulou Diamantis, Evanthia

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

1530-0285

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

18 Sep 2023 17:16

Last Modified:

19 Nov 2023 00:16

Publisher DOI:

10.1016/j.modpat.2023.100328

PubMed ID:

37714333

BORIS DOI:

10.48350/186354

URI:

https://boris.unibe.ch/id/eprint/186354

Actions (login required)

Edit item Edit item
Provide Feedback